» Authors » Omar S Aljitawi

Omar S Aljitawi

Explore the profile of Omar S Aljitawi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 860
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Pokhrel S, Persons D, Aljitawi O
Case Rep Hematol . 2016 Mar; 2016:8628507. PMID: 26949553
Respiratory syncytial virus (RSV) infections are associated with thrombocytopenia. The underlying mechanism of thrombocytopenia in this setting is unknown. Herein, we report a case of RSV-related thrombocytopenia associated with transient...
22.
Hari P, Aljitawi O, Arce-Lara C, Nath R, Callander N, Bhat G, et al.
Biol Blood Marrow Transplant . 2015 Sep; 21(12):2100-2105. PMID: 26327631
Autologous stem cell transplantation (ASCT) after high-dose melphalan conditioning is considered a standard of care procedure for patients with multiple myeloma (MM). Current formulations of melphalan (eg, Alkeran for Injection...
23.
Ciurea S, Zhang M, Bacigalupo A, Bashey A, Appelbaum F, Aljitawi O, et al.
Blood . 2015 Jul; 126(8):1033-40. PMID: 26130705
We studied adults with acute myeloid leukemia (AML) after haploidentical (n = 192) and 8/8 HLA-matched unrelated donor (n = 1982) transplantation. Haploidentical recipients received calcineurin inhibitor (CNI), mycophenolate, and...
24.
Brownback K, Simpson S, Pitts L, Polineni D, McGuirk J, Ganguly S, et al.
J Clin Apher . 2015 Jun; 31(4):347-52. PMID: 26031713
Extracorporeal photopheresis (ECP) is a commonly used treatment for severe graft-versus-host-disease (GVHD). We sought to evaluate the effects of ECP over a prolonged period on forced expiratory volume in 1...
25.
Lin T, Williams T, He J, Aljitawi O, Ganguly S, Abhyankar S, et al.
Cancer Med . 2015 Jan; 4(4):519-22. PMID: 25620650
In addition to cytogenetics, additional molecular markers of prognosis have been identified and incorporated into the management of patients with acute myeloid leukemia (AML). We hypothesized that rates of molecular...
26.
Jadalannagari S, Aljitawi O
Tissue Eng Part B Rev . 2014 Dec; 21(3):314-22. PMID: 25517045
Mesenchymal stem cells (MSCs) from Wharton's jelly (WJ) of the human umbilical cord are perinatal stem cells that have self-renewal ability, extended proliferation potential, immunosuppressive properties, and are accordingly excellent...
27.
Pawar R, Williams T, Khera R, Eid A, Aljitawi O, Dusing R
J Blood Med . 2014 Mar; 5:37-41. PMID: 24648782
Neutropenic sepsis is a common clinical entity occurring in postchemotherapy patients. Infection may not be the cause of fever in such patients after neutrophil-count recovery. Herein, we present two patients...
28.
Brownback K, Simpson S, McGuirk J, Lin T, Abhyankar S, Ganguly S, et al.
Ann Hematol . 2013 Dec; 93(5):847-54. PMID: 24346710
Pre-engraftment syndrome (PES) is a condition occurring after umbilical cord blood transplantation (UCBT) characterized by fever and erythematous skin rash prior to neutrophil engraftment. We sought to determine the incidence...
29.
Aljitawi O, McGuirk J
J Comp Eff Res . 2013 Nov; 1(1):57-70. PMID: 24237297
High-dose chemotherapy and autologous stem cell transplantation remains a standard procedure in relatively young and selected older patients with multiple myeloma. High-dose melphalan has remained the chemotherapeutic agent of choice...
30.
Deauna-Limayo D, Aljitawi O, Ganguly S, Abhyankar S, Wick J, McGuirk J
J Oncol Pharm Pract . 2013 Sep; 20(4):263-9. PMID: 24005093
Background: The current standard for prevention of chemotherapy-induced nausea/vomiting in autologous stem cell transplant only achieves 4-20% emetic control. Objectives: To assess emetic responses to multiday palonosetron, aprepitant, and low-dose...